3Satoh K, Ikeda Y, Shieda S, et al. Edaravone scavenges nitric oxide [J]. Redox Rep, 2002, 7(4) : 219 -222.
4Okarmra K, Tsubokawa T, Johshita H, et al. FAaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia[ J]. Neurol Res, 2014, 36( 1 ) : 65 -69.
5Inoue Y, Yabe T, Okada K, et al. Effect of edaravone on acute brainstem-cerebellar infarction with vertigo and sudden hearing loss [J]. Auris Nasus Larynx, 2014, 41(3) : 303 -306.
6Wu S, Sena E, Egan K, et al. Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: a systematic review[ J]. Int J Stroke, 2014, 9(1 ) : 101 -106.
7MacLean M A, Diez-Cecilia E, Lavery C B, et al. Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid[J]. Bioorg Med Chem Lett, 2016, 26 (1): 100 - 104.
8Sheng X, Hua K, Yang C, et al. Novel hybrids of 3-n-butylphthalide and edaravone: Design, synthesis and evaluations as potential anti-isehemic stroke agents [ J ]. Bioorg Med Chem Lett, 2015, 25 ( 17 ) : 3535 - 3540.
9Oliveira-Filho J, Ornellas A C, Zhang C R, et al. COX-2 rs20417 polymorphism is associated with stroke and white matter disease[ J]. J Stroke Cerebrovasc Dis, 2015, 24(8) : 1817 -1822.
10Tabassmn R, Vaibhav K, Ytrivastava P, et al. PeriUyl alcohol improves functional and histological outcomes against ischemia-reperfusion injury by attenuation of oxidative stress and repression of COX-2, NOS-2 and NF-KB in middle cerebral artery occlusion rats[ J]. Eur J Pharmacol, 2015, 747 : 190 - 199.
